Healthcare

Project Manager - Motionstrand - San Diego, CA

1 day ago   |   San Diego Biotechnology   |   8 articles

Since 2003, Motionstrand has delivered exceptional digital customer experiences for clients in the pharma, biotech, medical device and regulated healthcare... $75,000 a...
Read more ...

A systematic review of the attributes of electronic personal health Records for Patients with multiple sclerosis

1 day ago   |   Springer

Abstract The personal health record is a novel information technology in the domain of health. In recent decades, PHR has been employed as an emerging tool for the improvement...
Read more ...

Eli Lilly and Company: Biologist-Protein Mass Spectrometry

3 days ago   |   San Diego Biotechnology

Eli Lilly and Company: At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indiana San...
Read more ...

GHO Capital raises over $1bn, Eyes Biotech Outsourcing Services

GHO Capital raises over $1bn, Eyes Biotech Outsourcing Services

6 days ago   |   Xconomy

GHO Capital will use the money raised to invest in healthcare, including outsourced service providers, which are seeing demand from smaller biotechs, according to a Jefferies...
Read more ...

Electrical Design Engineer - Genesis Engineers - Carlsbad, CA

10 days ago   |   San Diego Biotechnology   |   2 articles

Experience with the Pharmaceutical, Biotech, and Healthcare industries a plus. Leadership opportunities for rising stars. A culture of collaboration, by design.From Genesis...
Read more ...

Acceptance Prediction for Answers on Online Health-care Community

13 days ago   |   BMC Bioinformatics

With the development of e-Health, it plays a more and more important role in predicting whether a doctor's answer can be accepted by a patient through online healthcare...
Read more ...

Terso Solutions Announces 2020 Tradeshow Participation

14 days ago   |   San Diego Biotechnology

MADISON, Wis., Nov. 26, 2019 /PRNewswire/ - Terso Solutions, the leading provider of automated inventory management solutions for tracking high-value medical and scientific...
Read more ...

NuVasive to Present at the 31st Annual Piper Jaffray Healthcare Conference

15 days ago   |   San Diego Biotechnology

SAN DIEGO, Nov. 25, 2019 /PRNewswire/ - NuVasive, Inc. , the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive...
Read more ...

Precision BioSciences Welcomes Healthcare Industry Expert, Kevin J. Buehler, to its Board of Directors

16 days ago   |   Precision Biosciences


Read more ...

Director National Accounts - West Region - Immunomedics, Inc. - San Diego, CA

18 days ago   |   San Diego Biotechnology   |   3 articles

Combines knowledge of the healthcare and biotechnology industries with evolving payer trends, competitors' strategies, customer business models, legislative /...From...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Perceptive Unveils New $200M Fund to Invest in Early-Stage Biotechs

Perceptive Unveils New $200M Fund to Invest in Early-Stage Biotechs

Perceptive Advisors, an investment firm with a long track record of life science investing across all points of development, is now stepping up to pump money into companies at... Read more ...

Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule

Merck Makes a Big Blood Cancer Bet With $2.7B Deal for ArQule

Merck is acquiring cancer drug developer ArQule for $2.7 billion , a cash deal that brings it a promising early-stage compound that could challenge a blockbuster leukemia drug... Read more ...

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

KalVista Pharma Eye Drug Partnered With Merck Flunks Phase 2 Test

A KalVista Pharmaceuticals eye drug at the center of a research collaboration with Merck has failed a mid-stage clinical trial. KalVista developed its drug, KVD001, to treat... Read more ...

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules

Zentalis Pharmaceuticals is banking on small molecules for cancer-leaving the “cool technologies” aside for a “tried and true” approach, says the CEO, who wants to let the... Read more ...

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer

The Scripps Research Institute and AbbVie have agreed to broaden an existing drug discovery agreement focused on cancer cell therapies to now encompass treatments for other... Read more ...

Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego's Synthorx

Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego's Synthorx

Synthorx is working to design new cytokine therapies for cancer using an “extended” genetic alphabet that could help avoid the shortcomings associated with earlier versions... Read more ...

Artificial Pancreas Keeps Patients Healthier: A Perspective

Artificial Pancreas Keeps Patients Healthier: A Perspective

The late Mayo endocrinologists Russell Wilder, M.D., and Randall Sprague, M.D., would be smiling today at the news for patients with diabetes. Much of their lives and careers... Read more ...

Aurinia Plans FDA Filing After Lupus Nephritis Drug Hits Phase 3 Goals

Aurinia Plans FDA Filing After Lupus Nephritis Drug Hits Phase 3 Goals

Aurinia shares spiked last week after voclosporin, an immunosuppressant being tested in patients with lupus nephritis, met its primary and secondary endpoints in a Phase 3... Read more ...

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

After joining AstraZeneca's Boston Bio Hub incubator last year, Gatehouse Bio is now teaming up with the pharma company to identify potential drug targets in respiratory and... Read more ...

Business Development Manager, Europe - Invetech - San Diego, CA

Selling a combination of consulting services and technical product solutions in biotech, cell and gene therapy markets. Global VP Commercial .From Fortive - Tue, 10 Dec 2019... Read more ...